Category

News

Clinical benefit from immune checkpoint inhibition in advanced melanoma and NSCLC can be predicted by tyrosine kinase activity profiling

Blood-based biomarker test has the potential to decrease the number of both over- and undertreated patients improving overall response rate, reduce unnecessary side effects and help saving costs. PamGene, a...
Read More

PamGene announces presentation of positive interim results for its blood-based biomarker test to predict clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC at the 2020 European Society for Medical Oncology ESMO

PamGene, a biotech and services company focused on the development and commercialization of multiple novel biomarker panels for patient stratification in immuno-oncology, is pleased to announce that new data from...
Read More

Computational Modeling – mini Symposium

The University of Toledo College of Medicine and Life SciencesDepartment of Neurosciences invites you to: A Virtual Mini Symposium: Computation Modeling Signaling Change: Interrogating Protein Kinase signaling with Bioinformatics and Computational...
Read More

The identification of a novel FES substrate

Checking in on Biochemical Kinase behaviour Real-time measurement and understanding of kinase activity serve many purposes. It allows insights in cellular signaling and pathway elucidation but also target interactions. Recently...
Read More

ISO Accreditation for the Diagnostic Assay Services Lab

On February 18, 2019 PamGene has received the Certificate of Approval by Lloyd’s Register for the ISO 13485:2016 for it’s Management System. PamGene has developed a blood-based diagnostic test with...
Read More

At ASCO 2018: Predictive biomarkers for immunotherapy in Melanoma

PamGene is active in the area of diagnostics research and is in the process of developing clinical biomarkers for therapy response. There is an urgent need to properly predict clinical...
Read More

AACR 2018 follow-up

April 2018 This year’s American Association for Cancer Research (AACR) Annual Meeting, held from April 14th to 18th in Chicago, had a focus on “Driving Innovative Cancer Science to Patient...
Read More

Spotlight on Uveal Melanoma: The UM CURE PROJECT

Uveal melanoma is a cancer (melanoma) of the eye occurring in the uvea (iris, ciliary body, and choroid) and arising from uveal melanocytes (pigment cells). The “UMCure2020” Uveal Melanoma (UM)...
Read More

PamGene Posters at the Japanese Cancer Association Meeting

Dr. Tadashi Kondo and researchers from the National Cancer Center (NCC) presented posters with novel insights into therapeutic target discovery and strategy using PamGene data, at the 76th Annual meeting...
Read More

Prognostic biomarkers for lung cancer

Dr. Stephan Arni and researchers at the University of Zurich, Switzerland have shown how kinomic profiling can be used to discover prognostic biomarkers in lung cancer, that could potentially provide...
Read More
1 2 3